Compare DexCom, Inc. (DXCM) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs United Parcel Service Inc — how do they compare? DexCom, Inc. trades at $83.63 (market cap $31.86B), while United Parcel Service Inc trades at $94.82 (market cap $80.08B). The key difference: United Parcel Service Inc is far larger — about 2.5× DexCom, Inc.'s market cap, and United Parcel Service Inc pays a 6.97% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and United Parcel Service Inc for 141 Days on average.
| DXCM | UPS | |
|---|---|---|
Market Cap | $31.86B | $80.08B |
Volume | 3,607,070 | 6,706,833 |
Sector | Health | Industrials |
52-Week High | $92.34 | $120.00 |
52-Week Low | $54.84 | $82.87 |
Typical Hold Time | 62 Days | 141 Days |
Enterprise Value | $31.32B | $104.10B |
Dividend Yield | — | 6.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
UPS stock trades at $94.44, up 2.34% today, amid mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company shows stable profitability with 5.08% net margin and 29.66% ROE, though revenue has declined from $100.3B in 2022 to $88.66B in 2025. Recent Q2 2026 earnings beat expectations at $1.76 EPS versus $1.65 expected. Analyst sentiment is divided with 47% Buy ratings and a $118.67 consensus target, while recent news highlights margin pressures and competitive threats from Amazon.
The investment outlook for UPS balances attractive valuation (P/E 17.5, below industry average) and strong dividend yield near 7% against declining revenue trends and rising debt-to-asset ratio (33.02% in 2025). Key risks include domestic volume weakness, fuel cost pressures, and Amazon competition, but strategic initiatives like the TikTok Shop partnership and Secure Commerce platform offer growth potential. Wall Street's neutral-to-buy stance suggests cautious optimism for margin recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
